John Aballi, President and CEO of Exagen Inc. ($XGN), made three open market sales of company stock over the past year, totaling nearly $474,000. His latest sale occurred on March 3, 2026. These transactions rank 6,580th among nearly 12,000 insiders with sales, well below the average of $8.6 million and 6.4 transactions per insider. Aballi reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2026 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | A | Common Stock | 150000 | $0.00 | 880,235.0000 | 22,940,412 | 20.54% | 0.65% |
| March 12, 2026 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | A | Stock Option(right to buy) | 100000 | $3.16 | 175,000.0000 | 22,940,412 | 133.33% | 0.44% |
| March 3, 2026 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | A | Common Stock | 2535 | $3.08 | 730,235.0000 | 22,940,412 | 0.35% | 0.01% |
| March 3, 2026 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | S | Common Stock | 15698 | $3.62 | 727,700.0000 | 22,940,412 | 2.11% | 0.07% |
| Feb. 24, 2026 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | S | Common Stock | 11430 | $3.61 | 743,398.0000 | 22,940,412 | 1.51% | 0.05% |
| Oct. 16, 2025 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | S | Common Stock | 31787 | $11.82 | 754,828.0000 | 22,940,412 | 4.04% | 0.14% |
| Feb. 28, 2025 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | A | Common Stock | 8621 | $2.47 | 786,615.0000 | 18,203,044 | 1.11% | 0.05% |
| Feb. 21, 2025 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | A | Stock Option(right to buy) | 75000 | $3.58 | 75,000.0000 | 18,203,044 | 9999.99% | 0.41% |
| Feb. 21, 2025 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | A | Common Stock | 112500 | $0.00 | 777,994.0000 | 18,203,044 | 16.90% | 0.62% |
| Nov. 14, 2024 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | P | Common Stock | 24305 | $2.81 | 689,799.0000 | 18,254,937 | 3.65% | 0.13% |
| May 16, 2024 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | P | Common Stock | 40401 | $1.92 | 641,189.0000 | 17,679,467 | 6.72% | 0.23% |
| Feb. 29, 2024 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | A | Common Stock | 9804 | $1.91 | 600,788.0000 | 17,679,467 | 1.66% | 0.06% |
| Feb. 20, 2024 | EXAGEN INC. | $XGN | ABALLI JOHN | President and CEO | A | Common Stock | 175000 | $0.00 | 590,984.0000 | 17,679,467 | 42.07% | 0.99% |